Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
5.97
+0.09 (1.53%)
Apr 29, 2026, 4:00 PM EDT

SHA:688373 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-201.43-241.61-440.72-421.12-220.3-226.27
Depreciation & Amortization
14.2714.2714.1714.1215.312.11
Other Amortization
3.793.793.493.712.171.6
Loss (Gain) From Sale of Assets
-0-0-0.03-0-0.490.02
Loss (Gain) From Sale of Investments
-6.49-6.49-17.08-33.34-18.49-10.53
Stock-Based Compensation
14.4714.4737.5337.1428.2245.39
Provision & Write-off of Bad Debts
0.250.250.770.330.20.03
Other Operating Activities
8.5212.6712.889.187.065.13
Change in Accounts Receivable
-27.26-27.26-24.4111.47-58.49-14.76
Change in Inventory
2.682.68-15.42-15.63-10.88-5.58
Change in Accounts Payable
17.0617.06-18.8766.9228.7111.28
Change in Unearned Revenue
----1.85-130.6
Operating Cash Flow
-174.14-210.18-447.18-329.08-240.01-180.98
Capital Expenditures
-0.55-0.55-0.91-7.66-12.18-22.91
Sale of Property, Plant & Equipment
000.03-1.5-
Investment in Securities
145.05159.26495.51305.24-737.635
Other Investing Activities
-0.516.7820.1737.0514.8610.11
Investing Cash Flow
143.99165.49514.8334.63-733.4222.2
Long-Term Debt Issued
-205.710560148.7553.25
Long-Term Debt Repaid
--131.63-32.34-75.01-84.35-19.33
Net Debt Issued (Repaid)
4.7874.0772.66-15.0164.433.92
Issuance of Common Stock
3.113.111.98-981.775.09
Common Dividends Paid
-1.31--6.54-4.6-3.3-0.7
Other Financing Activities
-9.08-8.88---14.72-10.63
Financing Cash Flow
-2.568.3168.09-19.611,02827.68
Foreign Exchange Rate Adjustments
-2.27-2.020.140.451.16-0.2
Net Cash Flow
-34.9221.6135.86-13.6155.88-131.3
Free Cash Flow
-174.69-210.73-448.1-336.74-252.18-203.89
Free Cash Flow Margin
-115.99%-148.64%-343.97%-370.96%-523.13%-2661.81%
Free Cash Flow Per Share
-0.26-0.32-0.68-0.51-0.43-0.39
Cash Interest Paid
8.888.88----
Cash Income Tax Paid
12.3312.2227-9.87-7.20.39
Levered Free Cash Flow
-108.81-134.74-286.51-172.29-178.87-141.67
Unlevered Free Cash Flow
-100.75-126.69-279.54-165.95-173.36-138.4
Change in Working Capital
-7.52-7.52-58.260.9-53.67-8.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.